The 20 Best Spinal and Bulbar Muscular Atrophy Doctors Near Me in Hagerstown, MD

Kenneth Fischbeck is a Neurologist practicing medicine in Bethesda, Maryland. Dr. Fischbeck is rated as an Elite provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy (SMA), Primary Lateral Sclerosis, and Progressive Myoclonic Epilepsy.

Vinay Chaudhry is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Chaudhry is rated as a Distinguished provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Myasthenia Gravis, Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, and Advanced Bronchoscopy.

Chandana Chauhan is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Chauhan is rated as a Distinguished provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy (SMA), and Spinal Muscular Atrophy Type 3.

Dr. Jeffrey Rothstein focuses on neuromuscular diseases, with a particular focus on Amyotrophic lateral sclerosis (ALS). Other clinical areas relevant to his laboratory-based research include idiopathic stupor, epilepsy, and motor neuron degeneration. His laboratory includes more than 25 post-doctoral fellows, neurology residents, neuromuscular fellows, junior faculty, undergraduate students, technicians, and ALS clinic staff. He has been the principal and/or local investigator in more than 20 national or international trials in ALS. He is the author of more than 360 articles on basic and clinical neuroscience. Dr. Rothstein's laboratory research is funded through the National Institutes of Health, the Dept of Defense, Target ALS, Maryland TEDCO, Alzheimer's Drug Discovery Foundation, the Muscular Dystrophy Association, the ALS Association, and Answer ALS. Dr. Jeffrey Rothstein received a masters degree in neurochemistry from the University of Chicago and a Ph.D. in physiology and biophysics from the University of Illinois Health Sciences Center. He then obtained his medical degree from the University of Illinois College of Medicine. He went on to complete an internship at the University of North Carolina Memorial Hospital before joining The Johns Hopkins for his residency. While at Johns Hopkins, he became chief resident in neurology and completed his fellowship in neuromuscular disease. He has been Professor of Neurology and Neuroscience at Johns Hopkins for more than 25 years. Dr. Rothstein is rated as a Distinguished provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), Spinal and Bulbar Muscular Atrophy, and Spinal Muscular Atrophy Type 3. Dr. Rothstein is board certified in American Board Of Psychiatry And Neurology.

Dr. Brett Morrison specializes in neuromuscular disorders in adults including peripheral neuropathies, amyotrophic lateral sclerosis, myasthenia gravis and muscle diseases. Dr. Morrison is currently the site principal investigator for clinical trials investigating new treatments for chronic inflammatory demyelinating polyneuropathy (CIDP) and painful diabetic peripheral neuropathy. Dr. Morrison's research interests include investigations into the mechanisms of nerve regeneration and common peripheral neuropathies. Current research focuses on better understanding the role of the immune system in peripheral nerves and targeting these pathways for the development of new treatments. Dr. Brett Morrison received his M.D. and Ph.D. from Mount Sinai Medical School in New York City. He completed his medical internship at the University of Maryland and residency in neurology at The Johns Hopkins Hospital. He then completed a fellowship in Clinical Neurophysiology at The Johns Hopkins Hospital. Dr. Morrison is rated as a Distinguished provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, and Spinal Muscular Atrophy (SMA). Dr. Morrison is board certified in American Board Of Psychiatry And Neurology.

Abdullah AlQahtani specializes in inherited and noninherited neuromuscular neurological diseases. Dr. AlQahtani obtained his medical degree from the King Saud University in Saudi Arabia. He also completed an internship and earned a master’s degree in public health from the University of Miami Miller School of Medicine, and he obtained residency training in neurology at the University Hospitals of Cleveland-Case Western Reserve University and the Louis Stokes Cleveland Department of Veterans Affairs Medical Center. After completing a neuromuscular fellowship at Case Western Reserve University, Dr. AlQahtani joined the neurogenetics branch of the National Institute of Neurological Disorders and Stroke. He worked on natural history studies of disease progression and phenotype-genotype correlation. His research focuses on the identification of biomarkers of disease progression in neuromuscular diseases. Dr. Alqahtani is rated as an Advanced provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Spinal and Bulbar Muscular Atrophy, Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). Dr. Alqahtani is board certified in American Board Of Psychiatry And Neurology.

Galen Joe is a Physiatrist practicing medicine in Bethesda, Maryland. Dr. Joe is rated as a Distinguished provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Spinal and Bulbar Muscular Atrophy, Chronic Graft Versus Host Disease (cGvHD), Muscle Atrophy, and Spinal Muscular Atrophy (SMA).

Peter Jin is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Jin is rated as an Advanced provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), and Gastrostomy.

Neil Porter is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Porter is rated as an Advanced provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Mononeuritis Multiplex, Multiple Mononeuropathy, Riboflavin Transporter Deficiency Neuronopathy, and Gastrostomy.

Dr. Ahmet Hoke is Professor of Neurology and Neuroscience, W. W. Smith Charitable Trust Professor of Neuroimmunology at Johns Hopkins School of Medicine, Director of the Daniel B. Drachman Division of Neuromuscular Diseases and Director of the Merkin Peripheral Neuropathy and Nerve Regeneration Center at Johns Hopkins University School of Medicine. He completed his medical training at Hacettepe University School of Medicine in Ankara, Turkey followed by his PhD studies in developmental neuroscience at Case Western Reserve University in Cleveland, Ohio, and neurology residency at Johns Hopkins Hospital. After completing his neuromuscular training at University of Calgary, Canada, he returned to Johns Hopkins University as faculty and rose through the ranks. He is the recipient of several awards including Derek Denny Brown Young Neurological Scholar Award (2005) and Wolfe Neuropathy Research prize (2018) given by the American Neurological Association, Myung Memorial Lecture Award (2017) by the Korean Neurological Association, Nejat Eczacibasi Medical Scientist Award (2019) by the Eczacibasi Foundation, Turkey, and Alan J. Gebhart Prize in Excellence in Neuropathy Research (2022) by the Peripheral Nerve Society. He is an Ex-Officio member of the Board of Directors of the American Neurological Association, and Vice-President of the Toxic Neuropathy Consortium. He serves on several editorial boards and is the Editor-in-Chief of Annals of Clinical and Translational Neurology. Dr. Hoke is rated as an Experienced provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Wallerian Degeneration, Peripheral Neuropathy, Tomaculous Neuropathy, Spinal Muscular Atrophy with Arthrogryposis, and Prostatectomy. Dr. Hoke is board certified in American Board Of Psychiatry And Neurology.

Dr. Moukheiber trained in neurology at Tufts Medical Center and completed his fellowship in movement disorders at Johns Hopkins. His primary interests include using telehealth/teleneurology to help bridge the gap between tertiary care available in well-funded facilities and the dearth of it in significantly underserved and remote areas; especially pertaining to movement disorders in general and ataxia in particular. He has worked with a number of non-government organizations and founded his own entity that provides home health care in the form of advanced nursing, physical therapy and occupational therapy to underserved communities in third world countries, with particular emphasis on neurodegenerative diseases. Dr. Moukheiber is rated as an Experienced provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Stiff Person Syndrome, Movement Disorders, Parkinson's Disease, and Drug Induced Dyskinesia. Dr. Moukheiber is board certified in American Board Of Psychiatry And Neurology.

Lindsay Zilliox is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Zilliox is rated as an Experienced provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Peripheral Neuropathy, Orthostatic Hypotension, Myasthenia Gravis, Familial Dysautonomia, and Gastrostomy.

Thien Nguyen is a Neurologist practicing medicine in Rockville, Maryland. Dr. Nguyen is rated as an Experienced provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Paraneoplastic Cerebellar Degeneration, Migraine, Athetosis, and Hereditary Sensory and Autonomic Neuropathy Type 2.

James Morgan is a Neurologist practicing medicine in Salisbury, Maryland. Dr. Morgan is rated as an Advanced provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal Muscular Atrophy (SMA), Spinal and Bulbar Muscular Atrophy, and Spinal Muscular Atrophy Type 3.

Shakti Nayar is a Neurologist practicing medicine in Chevy Chase, Maryland. She has been practicing medicine for over 17 years. Dr. Nayar is rated as an Advanced provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Peripheral Neuropathy, Beriberi, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Infantile Axonal Neuropathy.

Robert Paschall is a Neurologist practicing medicine in Salisbury, Maryland. Dr. Paschall is rated as an Advanced provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. He is also highly rated in 83 other conditions, according to our data. His clinical expertise encompasses Epilepsy, Stroke, Memory Loss, Seizures, and Gastrostomy.

Dr. Pardo's interest in transverse myelitis centers on management of acute myelitis, biomarkers of the disease in cerebrospinal fluid (CSF) and blood, and the role of neuroimmune factors in the pathogenesis of myelopathies. Along with others neurologists and health care providers in the Johns Hopkins Transverse Myelitis Center, Dr. Pardo focuses on a comprehensive approach in the diagnosis and management of myelopathies, myelitis, neuroimmunological and neuroinfectious disorders. Dr. Pardo is rated as an Experienced provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Acute Flaccid Myelitis (AFM), Neurosarcoidosis, Transverse Myelitis, Zika Virus Disease, and Gastrostomy. Dr. Pardo is board certified in American Board Of Psychiatry And Neurology.

Dr. Ricardo Roda earned a combined MD/PhD degree from University of Rochester and completed an adult neurology residency, followed by a clinical neuromuscular fellowship at Johns Hopkins University School of Medicine. During residency, Dr. Roda developed a special interest in both auto-immune disorders and genetic disorders. Following residency, he spent three years in neurogenetics branch of National Institute of Neurological Disorders and Stroke (NINDS) working with Dr. Craig Blackstone, focusing on the use of the newer DNA sequencing techniques in genetic diagnosis, and in establishing genotype/phenotype correlations neuromuscular disorders. His current clinical interests include developing testing strategies for undiagnosed genetic disorders and myasthenia gravis. Dr. Roda is rated as an Experienced provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Spastic Paraplegia Type 7, Hereditary Spastic Paraparesis, Myasthenia Gravis, and Spastic Paraplegia Type 2. Dr. Roda is board certified in American Board Of Psychiatry And Neurology.

Dr. Charlotte Sumner is a Professor of Neurology and Neuroscience at Johns Hopkins University School of Medicine. Dr. Sumner cares for patients with genetically-mediated neuromuscular diseases. Her practice is notable for a focus on individuals with inherited neuromuscular disorders of peripheral nerves and motor neurons, including spinal muscular atrophy (SMA) and Charcot-Marie-Tooth (CMT) disease. She co-directs the Johns Hopkins Muscular Dystrophy Association Care Center, the Spinal Muscular Atrophy (SMA), and the Charcot-Marie-Tooth (CMT) clinics, which deliver multidisciplinary clinical care, engage in international natural history studies, and provide cutting edge therapeutics. Dr. Sumner’s research focuses on developing treatments for degenerative disorders of motor neurons and peripheral nerves. Her laboratory uses human tissues and induced pluripotent cell lines, mouse models and cultured cells to characterize disease mechanisms and develop treatments. Dr. Charlotte Sumner received her medical degree from the University of Pennsylvania School of Medicine following undergraduate studies at Princeton University. She completed internal medicine internship and neurology residency at the University of California San Francisco, after which she returned to the east coast for a neuromuscular fellowship at Johns Hopkins and a neurogenetics fellowship in the Neurogenetics Branch at the National Institute of Neurological Disorders and Stroke. She joined the neurology faculty at Johns Hopkins in 2006. Dr. Sumner is rated as an Experienced provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Spinal Muscular Atrophy (SMA), Charcot-Marie-Tooth Disease, Primary Lateral Sclerosis, Spinal Muscular Atrophy Type 2, and Gastrostomy. Dr. Sumner is board certified in American Board Of Psychiatry And Neurology.

Dr. Arun Venkatesan serves as Director of the Johns Hopkins Encephalitis Center, where he directs clinical activities and research. At the center he has developed a multidisciplinary program devoted to optimizing diagnosis and management of patients with infectious and autoimmune encephalitis and understanding mechanisms of disease in order to develop more effective treatments. He also plays an active role in the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers. He received his undergraduate degree in biomedical engineering from the University of California, Berkeley in 1994, followed by a Ph.D. in microbiology and immunology and an M.D. from the University of California, Los Angeles. He completed his residency in neurology and fellowship in neuroinfectious and neuroinflammatory diseases at Johns Hopkins, after which he was appointed to the faculty in the department of neurology in 2007. His laboratory research focuses on defining causes and mechanisms of central nervous system injury in the setting of infection and neuroinflammation, with a goal towards developing protective and regenerative strategies. He has received funding from the National Institutes of Health, Howard Hughes Medical Institute, National Multiple Sclerosis Society, and Maryland Stem Cell Research Fund. Dr. Venkatesan is rated as an Experienced provider by MediFind in the treatment of Spinal and Bulbar Muscular Atrophy. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Encephalitis, Herpes Simplex Encephalitis, Anti-NMDA Receptor Encephalitis, and Multiple Sclerosis (MS). Dr. Venkatesan is board certified in American Board Of Psychiatry And Neurology.